Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the target of unusually large options trading on Wednesday. Stock investors acquired 1,885 put options on the company. This represents an increase of approximately 1,101% compared to the typical daily volume of 157 put options.
Evelo Biosciences Stock Down 50.0%
Evelo Biosciences stock opened at $0.00 on Thursday. Evelo Biosciences has a 12 month low of $0.00 and a 12 month high of $0.00. The stock has a market capitalization of $1,884.00, a price-to-earnings ratio of 0.00 and a beta of 0.38.
About Evelo Biosciences
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.
The company’s pipeline spans inflammatory, autoimmune and oncology indications.
Featured Articles
- Five stocks we like better than Evelo Biosciences
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- New gold price target
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
